Anthony Duncan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anthony Duncan has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Falk Hildebrand
Quadram Institute Bioscience
5 shared publications - Frederick J. Warren
Quadram Institute, Norwich Research Park, Norwich NR4 7UQ, UK
3 shared publications Andres Castillo
Australian National Phenome Centre and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Australia
2 shared publications- Andrés Bernal
Australian National Phenome Centre and Centre for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth, Australia
2 shared publications - Cathrina H. Edwards
Quadram Institute
2 shared publications Dominic Blunt
Department of Imaging, Charing Cross Hospital, Imperial NHS Trust, London, UK
2 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Effect of dietary chickpea structures on the small intestine metabolome and microbiome: a randomised crossover trial
The human gastrointestinal tract (GIT) is central to human physiology, yet our understanding of the metabolite, microbial, and hormonal spatiotemporal dynamics in humans is limited. How these environments respond to complex food structures and homeostatic mechanisms they generate is unknown in humans. In this randomised study, ten participants consumed chickpea-based meals with intact versus broken cellular structures, with sampling of oral, gastric, duodenal and ileal fluids. The primary outcome was the postprandial enteroendocrine hormone responses (GIP, GLP-1 and PYY); secondary outcomes were GIT metabolite profiles ( 1 H NMR) and ileal microbiota (shotgun metagenomics). We observed that food structure markedly altered the spatiotemporal trajectories of metabolites and dominant microbe, driving distinct enteroendocrine hormone responses. Broken-cell meals produced early GIT glucose and maltose peaks associated with rapid GIP responses, whereas intact-cell meals elevated duodenal amino acids and ileal sugars, amino acids and formate, enhancing GLP-1 and PYY responses. Microbial profiles exhibited rapid spatial reorganisation, with evidence that oral bacterial strains transmitted to the ileum, where their abundance was associated with local metabolites and PYY responses. These findings identify food structure as a determinant of postprandial gastrointestinal metabolism and enteroendocrine responses and suggest an underappreciated route for oral bacteria to reach the ileum via the food bolus and impact metabolism. ISRCTN registration: ISRCTN18097249.
- 15 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessEffect of dietary chickpea structures on the small intestine metabolome and microbiome: a randomised crossover trial
The human gastrointestinal tract (GIT) is central to human physiology, yet our understanding of the metabolite, microbial, and hormonal spatiotemporal dynamics in humans is limited. How these environments respond to complex food structures and homeostatic mechanisms they generate is unknown in humans. In this randomised study, ten participants consumed chickpea-based meals with intact versus broken cellular structures, with sampling of oral, gastric, duodenal and ileal fluids. The primary outcome was the postprandial enteroendocrine hormone responses (GIP, GLP-1 and PYY); secondary outcomes were GIT metabolite profiles ( 1 H NMR) and ileal microbiota (shotgun metagenomics). We observed that food structure markedly altered the spatiotemporal trajectories of metabolites and dominant microbe, driving distinct enteroendocrine hormone responses. Broken-cell meals produced early GIT glucose and maltose peaks associated with rapid GIP responses, whereas intact-cell meals elevated duodenal amino acids and ileal sugars, amino acids and formate, enhancing GLP-1 and PYY responses. Microbial profiles exhibited rapid spatial reorganisation, with evidence that oral bacterial strains transmitted to the ileum, where their abundance was associated with local metabolites and PYY responses. These findings identify food structure as a determinant of postprandial gastrointestinal metabolism and enteroendocrine responses and suggest an underappreciated route for oral bacteria to reach the ileum via the food bolus and impact metabolism. ISRCTN registration: ISRCTN18097249.
- Open Access
Protal: Ultra-fast metagenomic profiling and strain-resolved analysis
Large-scale metagenomic studies increasingly require taxonomic profiles that are sensitive, precise, strain-resolved and computationally tractable. Existing profilers typically trade taxonomic breadth, sensitivity, precision and speed against one another, limiting their utility for high-resolution microbiome analyses. Here we present protal — profiling through alignment — an ultra-fast alignment-based method for species-and strain-resolved profiling of metagenomes. Protal combines a newly developed alignment algorithm, machine-learning-based classification and conserved bacterial marker genes to profile species represented in the standardized and regularly updated GTDB taxonomy. Protal reliably profiles all 143,614 bacterial and archaeal species in GTDB r226 and achieved higher precision on CAMI2 benchmarks than all tested contemporary profilers, including MetaPhlAn 4, mOTUs4, sylph and Kraken2+Bracken (mean species-level precision 98.3% versus 97.5% for the next-best profiler, sylph). In custom benchmarks, protal showed particularly strong gains for rare species represented by a single reference genome and for highly complex communities containing 10,000 species (F1-score 9% and 14% higher than the second best profiler, respectively). At the strain level, protal reconstructs intraspecific phylogenetic relationships among detected bacteria with similar accuracy as StrainPhlAn 4; because protal produces precise alignments, the phylogenies can be de novo produced without reliance on reference strain collections. Unlike dedicated strain-profiling workflows, however, protal performs strain analysis concurrently with species-level profiling, making it up to 40-fold faster without requiring additional steps. Together, these features make strain-resolved profiling of thousands of metagenomes feasible on commodity hardware. The software, databases and tutorials are available at https://github.com/4less/protal and http://protal.earlham.ac.uk .
Open AccessProtal: Ultra-fast metagenomic profiling and strain-resolved analysis
Large-scale metagenomic studies increasingly require taxonomic profiles that are sensitive, precise, strain-resolved and computationally tractable. Existing profilers typically trade taxonomic breadth, sensitivity, precision and speed against one another, limiting their utility for high-resolution microbiome analyses. Here we present protal — profiling through alignment — an ultra-fast alignment-based method for species-and strain-resolved profiling of metagenomes. Protal combines a newly developed alignment algorithm, machine-learning-based classification and conserved bacterial marker genes to profile species represented in the standardized and regularly updated GTDB taxonomy. Protal reliably profiles all 143,614 bacterial and archaeal species in GTDB r226 and achieved higher precision on CAMI2 benchmarks than all tested contemporary profilers, including MetaPhlAn 4, mOTUs4, sylph and Kraken2+Bracken (mean species-level precision 98.3% versus 97.5% for the next-best profiler, sylph). In custom benchmarks, protal showed particularly strong gains for rare species represented by a single reference genome and for highly complex communities containing 10,000 species (F1-score 9% and 14% higher than the second best profiler, respectively). At the strain level, protal reconstructs intraspecific phylogenetic relationships among detected bacteria with similar accuracy as StrainPhlAn 4; because protal produces precise alignments, the phylogenies can be de novo produced without reliance on reference strain collections. Unlike dedicated strain-profiling workflows, however, protal performs strain analysis concurrently with species-level profiling, making it up to 40-fold faster without requiring additional steps. Together, these features make strain-resolved profiling of thousands of metagenomes feasible on commodity hardware. The software, databases and tutorials are available at https://github.com/4less/protal and http://protal.earlham.ac.uk .
- Open Access
- 16 June 2026
- Published by Springer Nature in Research Square
Dietary Modulation of The Human Small Intestine Metabolome and Microbiome
The human gastrointestinal tract (GIT) is central to human physiology, yet our understanding of the metabolite, microbial, and hormonal spatiotemporal dynamics in humans is limited. How these environments respond to complex food structures and homeostatic mechanisms they generate is unknown in humans. Here, we employ naso-enteral intubation to generate a spatiotemporally resolved, multimodal dataset spanning the oral cavity (salivary fluids), stomach, duodenum, and ileum of ten healthy participants. In a randomised study, participants consumed legume-based meals with different cellular structure (intact versus broken), revealing that food structure remarkedly altered metabolites and dominant microbe spatiotemporal trajectories in the GIT, driving distinct enteroendocrine hormone responses (GIP, GLP-1 and PYY). Broken-cell meals produced early glucose and maltose peaks in the GIT fluid associated with rapid GIP responses, whereas intact-cell meals elevated duodenal amino acids and ileal sugars, amino acids and formate, enhancing GLP-1 and PYY responses. We showed that quantified metabolites from the 1HNMR profiles and microbial profiles exhibit rapid spatial reorganisation, with evidence of transmission of oral bacterial strains to the ileum, where their abundance was associated with local metabolites and release of PYY. These findings suggest an underappreciated route for oral bacteria to reach the ileum via the food bolus and impact metabolism. Our unique dataset allows us to explore the interplay between local and systemic metabolism, microbiota, and host physiology, with implications for metabolic health. ISRCTN registration: ISRCTN18097249.
- 16 June 2026
- Published by Springer Nature in Research Square
Open AccessDietary Modulation of The Human Small Intestine Metabolome and Microbiome
The human gastrointestinal tract (GIT) is central to human physiology, yet our understanding of the metabolite, microbial, and hormonal spatiotemporal dynamics in humans is limited. How these environments respond to complex food structures and homeostatic mechanisms they generate is unknown in humans. Here, we employ naso-enteral intubation to generate a spatiotemporally resolved, multimodal dataset spanning the oral cavity (salivary fluids), stomach, duodenum, and ileum of ten healthy participants. In a randomised study, participants consumed legume-based meals with different cellular structure (intact versus broken), revealing that food structure remarkedly altered metabolites and dominant microbe spatiotemporal trajectories in the GIT, driving distinct enteroendocrine hormone responses (GIP, GLP-1 and PYY). Broken-cell meals produced early glucose and maltose peaks in the GIT fluid associated with rapid GIP responses, whereas intact-cell meals elevated duodenal amino acids and ileal sugars, amino acids and formate, enhancing GLP-1 and PYY responses. We showed that quantified metabolites from the 1HNMR profiles and microbial profiles exhibit rapid spatial reorganisation, with evidence of transmission of oral bacterial strains to the ileum, where their abundance was associated with local metabolites and release of PYY. These findings suggest an underappreciated route for oral bacteria to reach the ileum via the food bolus and impact metabolism. Our unique dataset allows us to explore the interplay between local and systemic metabolism, microbiota, and host physiology, with implications for metabolic health. ISRCTN registration: ISRCTN18097249.
- Open Access
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
Detecting signatures underlying the composition of biological data
Biological compositional data is inherently multidimensional and therefore difficult to visualize and interpret. To allow for the automatic decomposition of large compositional data and to capture gradients in co-occurring features, called signatures, we developed a new software package ‘cvaNMF’. Our benchmarks on synthetic data show the effectiveness of cross-validation and our novel signature-similarity method to identify a suitable decomposition using non-negative matrix factorization (NMF). This software provides a complete set of tools to identify and visualize biologically informative signatures which we demonstrate in a wide range of microbial and cellular datasets: ‘Enterosignatures’ detected in gut metagenomes differentiated human hosts with diverse diseases; five ‘terrasignatures’ from rhizosphere metagenomes differentiated root- or soil-associated microbiomes, while being refined enough to infer geographic distances between plants. Large-scale data from >13 000 metagenomes representing 25 biomes were decomposed into environmental and host-associated microbiomes based on five newly discovered signatures. Finally, analysis of the cell composition of non-small cell lung cancer samples allowed separation of cancerous and inflamed tissues based on four cell-type signatures.
- 26 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (22)
Open AccessDetecting signatures underlying the composition of biological data
Biological compositional data is inherently multidimensional and therefore difficult to visualize and interpret. To allow for the automatic decomposition of large compositional data and to capture gradients in co-occurring features, called signatures, we developed a new software package ‘cvaNMF’. Our benchmarks on synthetic data show the effectiveness of cross-validation and our novel signature-similarity method to identify a suitable decomposition using non-negative matrix factorization (NMF). This software provides a complete set of tools to identify and visualize biologically informative signatures which we demonstrate in a wide range of microbial and cellular datasets: ‘Enterosignatures’ detected in gut metagenomes differentiated human hosts with diverse diseases; five ‘terrasignatures’ from rhizosphere metagenomes differentiated root- or soil-associated microbiomes, while being refined enough to infer geographic distances between plants. Large-scale data from >13 000 metagenomes representing 25 biomes were decomposed into environmental and host-associated microbiomes based on five newly discovered signatures. Finally, analysis of the cell composition of non-small cell lung cancer samples allowed separation of cancerous and inflamed tissues based on four cell-type signatures.
- Open Access
Dietary bioactives increase gut microbiome diversity and alter host and microbial metabolite profiles
Objective: Dietary bioactives have been associated with positive health effects such as cardiovascular health, or having anti-diabetic properties. Many bioactive compounds survive digestion arriving in the colon, where the gut microbiome can further metabolise them to forms more available to the host. Previous work has shown diets such as the Mediterranean diet, enriched in plant bioactives, affecting the composition and diversity of the gut microbiome. However, it is unclear which factors in such whole diet interventions underlie these changes, such as the bioactives themselves, the percentage of dietary fibres or macronutrient composition. In the Dietary BIoactives and Microbiome DivErsity (DIME) study we investigated the impact of a diet rich in a wide range of plant bioactives compared to a low bioactive diet with matched total fibre intake. Design: We conducted a randomised crossover intervention trial to assess alterations to the gut microbiome, urinary and faecal metabolites in 20 healthy subjects receiving two-week high- or low-bioactive diets, separated by a 4-week washout period. Macronutrient and total fibre content was carefully matched between diets. Results: Alpha diversity of both microbial taxa and function increased in the high bioactive diet. Microbiome compositions between participants appear more similar after the high bioactive diet than low, suggesting that the high bioactive diet selected for bacteria with a similar functional spectrum. Both faecal and urinary metabolites were strongly impacted by the diet intervention, including o-coumaric acid, theobromine, and secondary bile acids. Metabolite profiles were more strongly associated to the dietary intervention arms than microbiome profiles, suggesting that a diet high in bioactives may change the activity of the existing community despite only small shifts in community composition. Conclusion: High intake of dietary bioactives leads to significant changes in both microbial and host metabolite profiles. However, the shift in microbiome composition was substantially less pronounced, highlighting the need of future studies to investigate metabolic activities instead of taxonomic compositions.
Open AccessDietary bioactives increase gut microbiome diversity and alter host and microbial metabolite profiles
Objective: Dietary bioactives have been associated with positive health effects such as cardiovascular health, or having anti-diabetic properties. Many bioactive compounds survive digestion arriving in the colon, where the gut microbiome can further metabolise them to forms more available to the host. Previous work has shown diets such as the Mediterranean diet, enriched in plant bioactives, affecting the composition and diversity of the gut microbiome. However, it is unclear which factors in such whole diet interventions underlie these changes, such as the bioactives themselves, the percentage of dietary fibres or macronutrient composition. In the Dietary BIoactives and Microbiome DivErsity (DIME) study we investigated the impact of a diet rich in a wide range of plant bioactives compared to a low bioactive diet with matched total fibre intake. Design: We conducted a randomised crossover intervention trial to assess alterations to the gut microbiome, urinary and faecal metabolites in 20 healthy subjects receiving two-week high- or low-bioactive diets, separated by a 4-week washout period. Macronutrient and total fibre content was carefully matched between diets. Results: Alpha diversity of both microbial taxa and function increased in the high bioactive diet. Microbiome compositions between participants appear more similar after the high bioactive diet than low, suggesting that the high bioactive diet selected for bacteria with a similar functional spectrum. Both faecal and urinary metabolites were strongly impacted by the diet intervention, including o-coumaric acid, theobromine, and secondary bile acids. Metabolite profiles were more strongly associated to the dietary intervention arms than microbiome profiles, suggesting that a diet high in bioactives may change the activity of the existing community despite only small shifts in community composition. Conclusion: High intake of dietary bioactives leads to significant changes in both microbial and host metabolite profiles. However, the shift in microbiome composition was substantially less pronounced, highlighting the need of future studies to investigate metabolic activities instead of taxonomic compositions.
- Open Access
- 4 April 2025
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 11 (1) , 1-14
A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease
Current treatment of Parkinson’s Disease (PD) remains symptomatic, and disease-modifying approaches are urgently required. A promising approach is to modify intestinal microbiota and key metabolites of bacterial fermentation: short-chain fatty acids (SCFA), which are decreased in PD. A prospective, controlled pilot study (DRKS00034528) was conducted on 11 couples (PD patient plus healthy spouse as control (CO)). Participants followed a 4-week diet rich in dietary fibre, including intake of the prebiotic Lactulose. Gut metagenomes, faecal and urinary metabolites, and clinical characteristics were assessed. The dietary intervention significantly augmented faecal SCFA and increased Bifidobacteria spp., reducing PD-related gastrointestinal symptoms. The pre-existing bacterial dysbiosis in PD (depletion of Blautia, Dorea, Erysipelatoclostridium) persisted. Bacterial metabolite composition in faeces and urine positively changed with the intervention: Brain-relevant gut metabolic functions involved in neuroprotective and antioxidant pathways, including S-adenosyl methionine, glutathione, and inositol, improved in PD. These promising results warrant further investigation in larger cohorts.
- 4 April 2025
- Published by Springer Nature in npj Parkinson's Disease
- Vol. 11 (1) , 1-14
Open AccessA prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease
Current treatment of Parkinson’s Disease (PD) remains symptomatic, and disease-modifying approaches are urgently required. A promising approach is to modify intestinal microbiota and key metabolites of bacterial fermentation: short-chain fatty acids (SCFA), which are decreased in PD. A prospective, controlled pilot study (DRKS00034528) was conducted on 11 couples (PD patient plus healthy spouse as control (CO)). Participants followed a 4-week diet rich in dietary fibre, including intake of the prebiotic Lactulose. Gut metagenomes, faecal and urinary metabolites, and clinical characteristics were assessed. The dietary intervention significantly augmented faecal SCFA and increased Bifidobacteria spp., reducing PD-related gastrointestinal symptoms. The pre-existing bacterial dysbiosis in PD (depletion of Blautia, Dorea, Erysipelatoclostridium) persisted. Bacterial metabolite composition in faeces and urine positively changed with the intervention: Brain-relevant gut metabolic functions involved in neuroprotective and antioxidant pathways, including S-adenosyl methionine, glutathione, and inositol, improved in PD. These promising results warrant further investigation in larger cohorts.
- Open Access
One year of gluten free diet impacts gut function and microbiome in celiac disease
BACKGROUND & AIMS: Currently, the main treatment option for coeliac disease (CD) is a gluten free diet (GFD). This observational cohort study investigated the impact of CD and 1 year of GFD on gut function and microbiome. METHODS: 36 newly diagnosed patients and 36 healthy volunteers (HV) were studied at baseline and at 12 months follow up. Small bowel water content (SBWC), whole gut transit time (WGTT) and colon volumes were measured by MRI. Stool samples DNA was subjected to shotgun metagenomic sequencing. Species level abundances and gene functions, including carbohydrate active enzymes (CAZymes) were determined. RESULTS: SBWC was significantly higher in people with CD 157±15 mL versus HVs 100±12 mL (p=0.003). WGTT was delayed in people with CD 68±8 hours versus HVs 41±5 hours (p=0.002). The differences reduced after 12 months of GFD but not significantly. Wellbeing in the CD group significantly improved after GFD but did not recover to control values. CD faecal microbiota showed high abundance of proteolytic gene functions, associated with Escherichia coli, Enterobacter and Peptostreptococcus . GFD significantly reduced Bifidobacteria and increased Blautia wexerelae . Microbiome composition correlated positively with WGTT, colonic volume and Akkermansia municphilia but negatively with B.wexerelae . Following GFD the reduction in WGTT and colonic volume significantly associated with increased abundance of B.wexerelae . There were also significant alterations in CAZyme profiles, specifically starch and arabinoxylan degrading families. CONCLUSIONS: CD impacted gut function and microbiota. GFD ameliorated but did not reverse these effects, significantly reducing Bifidobacteria associated with reduced intake of resistant starch and arabinoxylan from wheat.
Open AccessOne year of gluten free diet impacts gut function and microbiome in celiac disease
BACKGROUND & AIMS: Currently, the main treatment option for coeliac disease (CD) is a gluten free diet (GFD). This observational cohort study investigated the impact of CD and 1 year of GFD on gut function and microbiome. METHODS: 36 newly diagnosed patients and 36 healthy volunteers (HV) were studied at baseline and at 12 months follow up. Small bowel water content (SBWC), whole gut transit time (WGTT) and colon volumes were measured by MRI. Stool samples DNA was subjected to shotgun metagenomic sequencing. Species level abundances and gene functions, including carbohydrate active enzymes (CAZymes) were determined. RESULTS: SBWC was significantly higher in people with CD 157±15 mL versus HVs 100±12 mL (p=0.003). WGTT was delayed in people with CD 68±8 hours versus HVs 41±5 hours (p=0.002). The differences reduced after 12 months of GFD but not significantly. Wellbeing in the CD group significantly improved after GFD but did not recover to control values. CD faecal microbiota showed high abundance of proteolytic gene functions, associated with Escherichia coli, Enterobacter and Peptostreptococcus . GFD significantly reduced Bifidobacteria and increased Blautia wexerelae . Microbiome composition correlated positively with WGTT, colonic volume and Akkermansia municphilia but negatively with B.wexerelae . Following GFD the reduction in WGTT and colonic volume significantly associated with increased abundance of B.wexerelae . There were also significant alterations in CAZyme profiles, specifically starch and arabinoxylan degrading families. CONCLUSIONS: CD impacted gut function and microbiota. GFD ameliorated but did not reverse these effects, significantly reducing Bifidobacteria associated with reduced intake of resistant starch and arabinoxylan from wheat.
- 12 May 2022
- Published by Springer Nature
- p. 111-145
Structure and Evolution of Diatom Nuclear Genes and Genomes
- 12 May 2022
- Published by Springer Nature
- p. 111-145
Structure and Evolution of Diatom Nuclear Genes and Genomes